Mirae Asset Global ETFs Holdings’s Elicio Therapeutics ELTX Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio ELTX Stock Details ELTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$23.3K	Buy	+5,967	New	+$59.9K	﹤0.01%	3111

Other funds holding ELTX

KCM

Knoll Capital Management Miami, Florida $179M AUM 63.61% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Mirae Asset Global ETFs Holdings's ELTX Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings opened a new position in Elicio Therapeutics (ELTX) in Q2 2026: 5,967 shares worth $23.3K. The stake represents ﹤0.01% of the portfolio and ranks #3111 among its holdings.

48 funds tracked by Wall St. Rank hold ELTX as of Q2 2026.

Mirae Asset Global ETFs Holdings held 5,967 shares of Elicio Therapeutics worth $23.3K as of Q2 2026.
Elicio Therapeutics was a new Mirae Asset Global ETFs Holdings position in Q2 2026.
Elicio Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #3111 holding.
48 funds tracked by Wall St. Rank held Elicio Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.